Haiying Y. Chen
139 Ziqiang Rd
Shijiazhuang, 050000, China
Shijiazhuang, 050000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Vunakizumab in patients with active psoriatic arthritis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 study.
Journal: Rheumatology (Oxford, England)
Published: May 30, 2025
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 03, 2025
Aromatherapy with inhalation effectively alleviates the test anxiety of college students: A meta-analysis.
Journal: Frontiers in psychology
Published: September 12, 2022
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study.
Journal: Clinical rheumatology
Published: February 10, 2021
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.
Journal: Frontiers in pharmacology
Published: September 15, 2020
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: February 21, 2020
Cross-sectional study on clinic behavior and therapeutic status of patients with psoriatic arthritis in multi-center
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: December 19, 2019
Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional study.
Journal: International journal of rheumatic diseases
Published: October 23, 2018
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study.
Journal: Clinical and experimental rheumatology
Published: February 26, 2018
Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
Journal: Clinical rheumatology
Published: January 04, 2017
The impact of rheumatoid arthritis on work capacity in Chinese patients: a cross-sectional study.
Journal: Rheumatology (Oxford, England)
Published: February 13, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026